stockportfolio.pro
Stocks / RVMD vs VEEV
RVMD vs VEEV: Which Stock Is the Better Buy?
Revolution Medicines, Inc. and Veeva Systems Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
VEEV is the larger company ($31.3B vs $31.3B). On the fundamentals, VEEV has the stronger return on equity (12.6% vs -69.3%). Neither shows an obvious red flag in the filings. Full numbers below — the stronger figure on each row is in green.
AI verdict — RVMD vs VEEV, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Revolution Medicines, Inc. (RVMD) | Veeva Systems Inc. (VEEV) | |
|---|---|---|
| Market cap | $31.3B | $31.3B |
| Revenue (latest FY) | $0 | $3.20B |
| Net income (latest FY) | $-1.13B | $908.91M |
| Revenue growth (5y CAGR) | — | 16.9% |
| Net margin | — | 28.4% |
| Return on equity | -69.3% | 12.6% |
| P/E ratio | — | 34.1 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 10 |
| Positive free cash flow | No | — |
Compare with another company:
See the full RVMD vs VEEV breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open RVMD's full financials → Open VEEV's full financials →More comparisons
Frequently asked questions
Which is bigger, RVMD or VEEV?
Veeva Systems Inc. is larger by market capitalization — $31.3B versus $31.3B.
Which grows faster, RVMD or VEEV?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.